drugset / Trial / NCT01301586

A Novel Combination Oral Agent to Treat Acne Vulgaris

NCT01301586

Phase 1/2 Unknown 60 enrolled Nexgen Dermatologics, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females

Timeline

Start
2010-11
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator AUS-131 Small molecule Oral
Comparator Doxycycline Small molecule Oral

Indications